Gilead Sciences, Yipinhong Pharmaceutical and Mass General Brigham Ventures helped the slow-release drug developer secure series C cash bringing its overall funding to almost $250m.

GV participated in a series C round for the fertility and gynaecology services provider at a $612m valuation, doubling its overall funding.

Mastercard and Ally Ventures co-led a round which will support the credit card services provider's expansion, boosting its total funding to over $140m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Waste management software provider Recycle Track Systems bagged $35m in a Citi-led series C round while muscular dystrophy drug developer Vita Therapeutics completed a $32m series A.

Matt Garratt, who helped set up Salesforce Ventures, is taking a general partner role at venture firm CRV and is being replaced as managing partner by Alex Kayyal.

The OATV-backed user interface software provider increased its valuation fivefold to $10bn in a round co-led by Morgan Stanley and Durable Capital Partners.

Citi, Cuna Mutual Group and New York Life have contributed to a series D round for the financial advice provider at a valuation topping $1bn.

GV, Latacora and Salesforce Ventures helped the app development technology provider close its latest round, which will support hiring and research and development.

The data warehousing software developer has received cash from investors including GV, Telstra Ventures, M12 and National Grid Ventures to bring its total funding to $195m.